FDA approves Sagent heparin using packaging safety features
Sagent Pharmaceuticals’ heparin sodium injection, USP, which uses packaging and labelling safety features, has been approved by the US Food and Drug Administration (FDA).
The nine approved heparin products use PreventIV Measures technology to make it easier to distinguish between different concentrations. Each different product is given a unique colour and the drug name, concentration and fill volume are printed in easy to read text.
“I believe that features such as those incorporated into Sagent’s products can help reduce those errors caused by selecting the incorrect medication for a patient”, said Elaine Levy, system director, Pharmacy Sharp HealthCare.
